江河集團(601886.SH)擬6840萬元受讓淮安江河澤明眼科醫院60%股權
格隆匯12月26日丨江河集團(601886.SH)發佈公告,公司全資子公司北京江河維視眼科醫院有限公司與鄭波、曹靜、郯城明安企業管理合夥企業(有限合夥)於2019年12月26日簽訂了股權轉讓協議,約定以6840萬元受讓郯城明安持有淮安江河澤明眼科醫院有限公司60%的股權。
根據披露,淮安江河澤明眼科醫院有限公司註冊資本2000萬元,經營範圍包括眼科醫院診療服務;視功能保健訓練服務;醫療器械二類、三類、光學器材、文具、燈具、電子產品、預包裝食品銷售;眼鏡及護理產品訂配、光學驗光、加工、服務、銷售。(依法須經批准的項目,經相關部門批准後方可開展經營活動)。
淮安江河澤明眼科醫院為基於本次交易由淮安光明眼科醫院有限公司於2019年11月15日以整體眼科業務經營性資產注入設立的公司,眼科醫院已將與眼科相關的業務及人員注入到淮安江河澤明眼科醫院,同時將淮安清河醫院眼科診室的業務及人員通過託管方式納入到淮安江河澤明眼科醫院。
公告表示,上述股權轉讓協議的簽訂和履行對公司2019年度經營業績不構成重大影響。上述協議的簽訂將進一步加快公司眼科醫療業務的開拓,為公司下一步擴展國內眼科醫療業務市場帶來增量效應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.